A preclinical assessment of the effect of lipo-PGE1 on thrombus formation and thrombus disaggregation

Advanced Drug Delivery Reviews

Volumn 20, Issue 2-3, 1996, Pages 165-170

  Sim, A K ^a   McCraw, A P ^a   Cleland, M E ^a   Aihara, A ^b   Otomo, S ^b   Hosoda, K ^b   Araki, H ^b  

^a Inveresk Research   (United Kingdom)

^b TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Anti thrombotics; Drug targeting; Hamster cheek pouch; Liposomes; Microvasculature; Prostaglandin E1

Indexed keywords

BLOOD VESSELS; DISEASES; DRUG INFUSION; DRUG THERAPY; EFFECTS; LIPIDS; MICROCIRCULATION; PHARMACOKINETICS; PHYSIOLOGICAL MODELS;

DRUG TARGETING; HAMSTER CHEEK POUCH; LIPO PREPARATION; LIPOSOMES; MICROVASCULATURE; PROSTAGLANDIN E; THROMBUS DISAGGREGATING AGENT; THROMBUS GROWTH INHIBITOR; VASCULAR DAMAGE MODEL;

DRUG PRODUCTS;

ADENOSINE DIPHOSPHATE; LIPID; LIPOPROSTAGLANDIN E1; MICROSPHERE; PHOSPHOLIPID; PROSTAGLANDIN E1; SOYBEAN OIL;

ANIMAL MODEL; BLOOD CLOT LYSIS; CHEEK POUCH; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG FORMULATION; DRUG INFUSION; DRUG TARGETING; HAMSTER; IONTOPHORESIS; MALE; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; REGIONAL PERFUSION; SHORT SURVEY; THROMBOGENESIS; VASCULAR LESION;

EID: 0030602828     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-409X(95)00119-R     Document Type: Review

References (16)

1. [1] Nakano, J. (1973) Cardiovascular Actions. In: P.W. Ramwell (Ed), The Prostaglandins Vol. 1. Plenum Press, New York, NY, pp. 239-316.
2. 1 on platelet behaviour in vitro and in vivo. Br. Med. J. 22, 468-472.
3. [3] Smith, J.B. and MacFarlane, D.E. (1974) Platelets. In: P.W. Ramwell (Ed), The Prostaglandins, Vol. 2. Plenum Press, New York, NY, pp. 293-343.
4. 1 on experimental platelet aggregation in rats. In: R.J. Jones (Ed), Atherosclerosis: Proceedings of the Second International Symposium on Atherosclerosis, Chicago, IL. Springer, New York, NY, pp. 130-133.
5. 1. Br. Med. J. 281, 1031-1034.
6. temic sclerosis, Ann. Rheum. Dis. 40, 350-354.
7. 1 is more effective, when incorporated in lipid microspheres, for treatment of peripheral vascular diseases in man, J. Pharm. Pharmacol. 35, 666-667.
8. [8] Fendler, J.H. and Romero, A. (1977) Liposomes as drug carriers, Life Sci. 20, 1109-1120.
9. [9] Caride,V.J. and Zaret, B.L. (1977) Liposome accumulation in regions of experimental myocardial infarction. Science 198, 735-738.
10. [10] Papahadjopoulos, D., Poste, G., Vall, W.J. and Bredler, J.L. (1976) Use of lipid vesicles as carriers to introduce actinomycin D into resistant tumour cells. Cancer Res. 36, 2988-2994.
11. [11] Shaw, I.H., Knight, C.G., Thomas, D.P., Phillips, N.C. and Dingle, J.T. (1979) Liposome-incorporated corticosteroids. The interaction of liposomal cortisol palmitate with inflammatory synovial membrane, Br. J. Exp. Pathol. 60, 142-150.
12. [12] Phillips, N.C., Thomas, D.P., Knight, C.G. and Dingle, J.T. (1979) Liposomal incorporated corticosteroids II. Therapeutic activity in experimental arthritis. Ann. Rheum. Dis. 38, 553-557.
13. [13] de Silva, M., Hazleman, B.L., Thomas, D.P. and Wraight, P. (1979) Liposomes in arthritis: a new approach, Lancet i, 1320-1322.
14. [14] Mizushima, Y., Hamano, T. and Yokoyama, K. (1982) Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion, Ann. Rheum. Dis. 41, 263-267.
15. [15] Mizushima, Y., Wada, Y., Etoh, Y. and Watanabe, K. (1983) Anti-inflammatory effects of indomethacin ester incorporated in a lipid microsphere, J. Pharm. Pharmacol., 35, 398-399.
16. [16] Terragno, A., Rydzik, R. and Terragno, N.A. (1981) High performance liquid chromatography and UV detection for the separation and quantitation of prostaglandins. Prostaglandins 21, 101-112.